BioCentury | Jan 18, 2020
Finance

Novo seeks to REPAIR funding in antibiotics companies

...we not invested in Spero,” said Engel. The fund’s latest investments include $3.9 million in Integrated Biotherapeutics Inc.’s...
...to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta Biosystems Ltd. MinervaX ApS Integrated BioTherapeutics Inc. Polyphor...
BioCentury | Jan 18, 2020
Finance

Novo seeks to REPAIR funding in antibiotics companies

...we not invested in Spero,” said Engel. The fund’s latest investments include $3.9 million in Integrated Biotherapeutics Inc.’s...
...to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta Biosystems Ltd. MinervaX ApS Integrated BioTherapeutics Inc. Polyphor...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...Inc. , Amicrobe Inc. , Vedanta Biosciences Inc. , Seres Therapeutics Inc. (NASDAQ: MCRB) and Integrated BioTherapeutics Inc....
BioCentury | Mar 10, 2017
Company News

Integral Molecular, Integrated BioTherapeutics deal

...Integral Molecular and Integrated BioTherapeutics partnered to discover vaccines to prevent Ebola and Zika viral infections. Integral...
...vaccine, as well as use its epitope mapping technologies to characterize the protein’s protective effects. Integrated BioTherapeutics...
...terms. Integral Molecular Inc. , Philadelphia, Pa. Integrated BioTherapeutics Inc. , Rockville, Md. Business: Infectious Nora Weintraub Integral Molecular Inc. Integrated BioTherapeutics Inc....
BioCentury | Sep 29, 2016
Targets & Mechanisms

Two-timing Ebola

...generalizable to any virus with an intracellular target. Einstein has recruited Mapp Biopharmaceutical Inc. and Integrated BioTherapeutics Inc....
...two bispecific antibodies using three previously identified mAbs. The first, FVM09 , was discovered by Integrated BioTherapeutics Inc....
...Inc. (NYSE:ABBV), Chicago, Ill. Albert Einstein College of Medicine, Bronx, N.Y. Defyrus Inc., Toronto, Ontario Integrated BioTherapeutics...
BioCentury | Jun 2, 2016
Distillery Therapeutics

Therapeutics: Ebolavirus glycoprotein; Niemann-Pick disease type C1 (NPC1)

...K. et al. Cell Rep.; published online May 5, 2016 doi:10.1016/j.celrep.2016.04.026 CONTACT: M. Javad Aman, Integrated BioTherapeutics Inc....
BioCentury | Nov 17, 2014
Company News

Chembio, Integrated BioTherapeutics deal

...Chembio and Integrated BioTherapeutics partnered to develop point-of-care diagnostics for Ebola and febrile illness. Chembio will provide...
...develop point-of-care diagnostics for Ebola and febrile illness. Chembio will provide its DPP technology and Integrated BioTherapeutics...
...rights to any point-of-care product developed under the deal. Chembio Diagnostics Inc. (NASDAQ:CEMI), Medford, N.Y. Integrated BioTherapeutics Inc....
BioCentury | Feb 3, 2014
Company News

Integrated BioTherapeutics, Noble Life Sciences sales and marketing update

...Noble and Integrated BioTherapeutics' IBT Bioservices research services division launched an optimized cotton rat respiratory syncytial virus...
...RSV infection in the cotton rat and share rights to market and commercialize the service. Integrated BioTherapeutics Inc....
BioCentury | Jun 14, 2012
Distillery Techniques

Technology: Drug platforms

...et al. J. Biol. Chem.; published online May 29, 2012; doi:10.1074/jbc.M112.364075 Contact: M. Javad Aman, Integrated BioTherapeutics Inc....
BioCentury | Jun 20, 2011
Company News

Agenus, Integrated BioTherapeutics deal

...Agenus granted Integrated BioTherapeutics an exclusive, worldwide license to QS-21 Stimulon adjuvant for the development of a...
...to QS-21 Stimulon in 2006 (see BioCentury, July 17, 2006). Agenus Inc. (NASDAQ:AGEN), Lexington, Mass. Integrated BioTherapeutics Inc....
Items per page:
1 - 10 of 11
BioCentury | Jan 18, 2020
Finance

Novo seeks to REPAIR funding in antibiotics companies

...we not invested in Spero,” said Engel. The fund’s latest investments include $3.9 million in Integrated Biotherapeutics Inc.’s...
...to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta Biosystems Ltd. MinervaX ApS Integrated BioTherapeutics Inc. Polyphor...
BioCentury | Jan 18, 2020
Finance

Novo seeks to REPAIR funding in antibiotics companies

...we not invested in Spero,” said Engel. The fund’s latest investments include $3.9 million in Integrated Biotherapeutics Inc.’s...
...to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta Biosystems Ltd. MinervaX ApS Integrated BioTherapeutics Inc. Polyphor...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...Inc. , Amicrobe Inc. , Vedanta Biosciences Inc. , Seres Therapeutics Inc. (NASDAQ: MCRB) and Integrated BioTherapeutics Inc....
BioCentury | Mar 10, 2017
Company News

Integral Molecular, Integrated BioTherapeutics deal

...Integral Molecular and Integrated BioTherapeutics partnered to discover vaccines to prevent Ebola and Zika viral infections. Integral...
...vaccine, as well as use its epitope mapping technologies to characterize the protein’s protective effects. Integrated BioTherapeutics...
...terms. Integral Molecular Inc. , Philadelphia, Pa. Integrated BioTherapeutics Inc. , Rockville, Md. Business: Infectious Nora Weintraub Integral Molecular Inc. Integrated BioTherapeutics Inc....
BioCentury | Sep 29, 2016
Targets & Mechanisms

Two-timing Ebola

...generalizable to any virus with an intracellular target. Einstein has recruited Mapp Biopharmaceutical Inc. and Integrated BioTherapeutics Inc....
...two bispecific antibodies using three previously identified mAbs. The first, FVM09 , was discovered by Integrated BioTherapeutics Inc....
...Inc. (NYSE:ABBV), Chicago, Ill. Albert Einstein College of Medicine, Bronx, N.Y. Defyrus Inc., Toronto, Ontario Integrated BioTherapeutics...
BioCentury | Jun 2, 2016
Distillery Therapeutics

Therapeutics: Ebolavirus glycoprotein; Niemann-Pick disease type C1 (NPC1)

...K. et al. Cell Rep.; published online May 5, 2016 doi:10.1016/j.celrep.2016.04.026 CONTACT: M. Javad Aman, Integrated BioTherapeutics Inc....
BioCentury | Nov 17, 2014
Company News

Chembio, Integrated BioTherapeutics deal

...Chembio and Integrated BioTherapeutics partnered to develop point-of-care diagnostics for Ebola and febrile illness. Chembio will provide...
...develop point-of-care diagnostics for Ebola and febrile illness. Chembio will provide its DPP technology and Integrated BioTherapeutics...
...rights to any point-of-care product developed under the deal. Chembio Diagnostics Inc. (NASDAQ:CEMI), Medford, N.Y. Integrated BioTherapeutics Inc....
BioCentury | Feb 3, 2014
Company News

Integrated BioTherapeutics, Noble Life Sciences sales and marketing update

...Noble and Integrated BioTherapeutics' IBT Bioservices research services division launched an optimized cotton rat respiratory syncytial virus...
...RSV infection in the cotton rat and share rights to market and commercialize the service. Integrated BioTherapeutics Inc....
BioCentury | Jun 14, 2012
Distillery Techniques

Technology: Drug platforms

...et al. J. Biol. Chem.; published online May 29, 2012; doi:10.1074/jbc.M112.364075 Contact: M. Javad Aman, Integrated BioTherapeutics Inc....
BioCentury | Jun 20, 2011
Company News

Agenus, Integrated BioTherapeutics deal

...Agenus granted Integrated BioTherapeutics an exclusive, worldwide license to QS-21 Stimulon adjuvant for the development of a...
...to QS-21 Stimulon in 2006 (see BioCentury, July 17, 2006). Agenus Inc. (NASDAQ:AGEN), Lexington, Mass. Integrated BioTherapeutics Inc....
Items per page:
1 - 10 of 11